Categories
Health

Delta Plus, a New Variant, Raises Considerations in India

As India reopens after a devastating second wave of coronavirus infections, virologists worry that another, potentially more virulent version of the virus could accelerate the onset of a third wave within a few months.

The version known locally as Delta Plus is described by scientists as a sub-line of the highly contagious Delta variant, which has quickly spread to India, the UK, the US, and other countries. The new variant carries a spike protein mutation, which can also be found in the beta variant, which was first identified in South Africa, although it is unclear how this common mutation could affect the function of the variant.

Reports suggest that cases of Delta Plus have been found in nearly a dozen countries, including the United States. In India, Delta Plus was first detected in April in the western state of Maharashtra. Authorities in India this week declared it a new “worrying variant” in the country after finding more than 40 cases in three states: Maharashtra, Madhya Pradesh and Kerala.

The Indian Ministry of Health announced this week that Delta Plus has shown increased portability. States where the variant was found have been asked to step up testing, improve surveillance, and speed up contact tracing to try to prevent it from spreading.

Due to its recent discovery, studies of this particular variant have not yet been carried out, so scientists have limited information. However, they have begun to speculate about their ability to spread.

“It is most likely able to evade immunities,” said Shahid Jameel, virologist and director of the Trivedi School of Biosciences at Ashoka University in Sonipat, India. “That’s because it carries all of the symptoms of the original Delta variant as well as its partner beta variant.”

Indian Health Ministry officials stressed that both Covid vaccines that are widely used in the country – the AstraZeneca vaccine made by the Serum Institute of India and the Covaxin vaccine made by Indian company Bharat Biotech – are likely to be effective against variants, including Delta are pluses.

Understand the Covid crisis in India

India’s vaccination campaign picked up pace this week, with more than 6.7 million people vaccinated across the country on Thursday, according to official figures. Prime Minister Narendra Modi’s government has stated that the syringes should be offered free to all adults in support of vaccination efforts that have been hampered by mismanagement and lack of care. About 5.5 percent of the population are fully vaccinated, and 18 percent have received at least one vaccination.

In Maharashtra, one of the hardest hit states, officials said Delta Plus was becoming a significant problem and warned that if cases increased, they would reintroduce restrictions.

“We are at the end of a second wave and will be careful how we unlock,” said Rajesh Tope, the country’s health minister. “The lessons we learned from dealing with the second wave are used to stop the spread of any new variant.”

Delta Plus was also identified this month by UK health officials calling it Delta-AY.1. They wrote in a June 11 report that they had discovered 36 cases, the first five of which were contacts from people who had recently traveled through Nepal and Turkey. Half of the 36 cases occurred in people who were not vaccinated and none of the cases resulted in death, but the report warned that “limited epidemiological information” was available about the variant.

Categories
Health

5 issues to know earlier than the inventory market opens Friday, June 25

Here are the top news, trends, and analysis investors need to start their trading day:

1. Wall Street is heading for its best week in months

A Wall Street sign is pictured outside the New York Stock Exchange amid the coronavirus disease (COVID-19) pandemic in the Manhattan neighborhood of New York on April 16, 2021.

Carlo Allegri | Reuters

US stock futures rose Friday, the day after the S&P 500 and Nasdaq closed at record highs, fueled by President Joe Biden’s signing of an infrastructure deal with a bipartisan group of senators. The Dow also rose Thursday, gaining 322 points, or nearly 1%, heading for its best weekly gain since March. The 30-share average is about 1.6% off its record high in early May after last week’s worst weekly decline since October. The S&P 500 and Nasdaq had their best weeks since April.

  • Dow stock Nike rose 13% in the premarket and is likely to open at an all-time high. The athletic shoe and apparel giant topped estimates for quarterly earnings and sales late Thursday. Nike saw a 73% increase in direct sales through its apps and websites. Nike’s stock pop is responsible for much of the surge in the Dow futures.
  • Virgin Galactic is up 14% after the FAA was given the green light to fly passengers into space. “The commercial license we held since 2016 remains in place, but is now approved to carry commercial passengers when we are ready,” Michael Colglazier, CEO of Virgin Galactic, told CNBC.

2. The Fed’s most popular inflation indicator is hot

3. Infrastructure compromise includes $ 579 billion in new spending

US President Joe Biden speaks after a bipartisan meeting with US Senators on the proposed framework for the Infrastructure Bill on June 24, 2021 at the White House in Washington.

Kevin Lamarque | Reuters

The bipartisan infrastructure compromise includes $ 579 billion in new spending, of which $ 312 billion will be used on transportation projects such as roads, bridges and trains. The plan also puts $ 266 billion into non-transport infrastructure, including power, water and broadband internet improvements. Only $ 15 billion goes into infrastructure for electric vehicles and electric buses and public transportation, a fraction of what Biden originally proposed. How they should pay for all of this remains under discussion. The Democratic leaders on Capitol Hill want to pass the bipartisan framework along with a larger bill to address more of their priorities without a Republican vote.

4. The search for survivors of the building collapse in Florida continues

This aerial view shows search and rescue workers working on site after the partial collapse of the Champlain Towers South in Surfside, north of Miami Beach, on June 24, 2021.

Chandan Khanna | AFP | Getty Images

Biden has promised to provide federal aid, if requested, in finding survivors of a partial collapse of a beachfront condo outside of Miami. At least one person was killed and nearly 100 people are still missing. Officials did not know how many people were in the tower when it collapsed in Surfside at around 1:30 a.m. ET early Thursday morning. Florida Governor Ron DeSantis, who toured the scene, said the rescue teams would “do anything to save lives. Authorities did not say what might have caused the collapse.

5. Chauvin could be sentenced for decades on Floyd’s death

A woman reacts following the verdict in the trial of former Minneapolis Police Officer Derek Chauvin, convicted of the death of George Floyd, on April 20, 2021 at BLM Plaza in Washington, DC.

Evelyn Hockstein | Reuters

Former Minneapolis Police Officer Derek Chauvin is convicted Friday of the murder of George Floyd’s death in a case that sparked worldwide outrage and a racial reckoning in America. Legal experts predict that Chauvin, 45, could live to be 20 to 25 years old. He was convicted of accidental second degree murder, third degree murder, and second degree manslaughter. While he is widely expected to appeal, Chauvin is also facing trial on federal civil rights charges along with three other dismissed officials whose state trials are pending.

– The Associated Press contributed to this report. Follow the whole market like a pro on CNBC Pro. Get the latest on the pandemic with coronavirus coverage from CNBC.

Categories
Health

Tips on how to Train within the Summer time Warmth

We also should accustom ourselves, slowly, to unfamiliar swelter, Dr. Gibson says, a process known to exercise scientists as acclimatizing, which involves working out sometimes, by choice, when the day is warmest. This approach helps to condition our bodies to better cope with the heat. Once acclimatized, we will sweat earlier and more abundantly than before, dissipating internal heat better and leaving us feeling bouncier and less fatigued.

Acclimatizing should be gradual, however. To start, slather on sunscreen, fill a water bottle, head outside after about 10 a.m., when temperatures intensify, and try to complete a gentler version of your standard workout, says Carl James, a senior physiologist at the National Sports Institute in Kuala Lumpur, Malaysia, and co-author of the review. If you usually run for 30 minutes, for instance, maybe jog for 20, and monitor how you feel. If your heart seems to be racing, he says, or you feel lousy, “slow down.”

After a few acclimatization sessions, you should notice your clothes and skin are drenched, Dr. Gibson says. Congratulations. “Earlier and more profuse sweating is a great sign that heat adaptation is taking place,” he says. Most of us acclimatize after about five to 10 hot workouts, he adds, although women, who tend to sweat less freely than men, may require an extra easy session or two to be fully prepared for harder workouts in the heat.

After each acclimatization session, head for the showers, but dial up the heat. Standing under a warm shower spray or soaking in a hot bathtub for 10 minutes or so after a sweltering workout prompts our bodies to continue acclimatizing, Dr. Gibson says. “It extends the stimuli for heat adaptation,” he points out, “and is therefore welcome and beneficial.”

An icy beverage before a hot workout “will help with hydration and provide a combination of perceptual and actual cooling,” Dr. Gibson says. Aim to drink about 16 ounces of cold fluid 20 minutes or so before you head out. Drinking closer to the session’s start could cause stomach upset during your workout.

Categories
Health

UK carefully watched with its vaccine program and surge in circumstances

New Yorkers, 12 and older, will be vaccinated on June 13, 2021 at the St. Anthony of Padua Roman Catholic Church in the Bronx of New York City, United States.

Tayfun Coskun | Anadolu Agency | Getty Images

LONDON – The UK has one of the highest Covid-19 vaccination rates in the world but is seeing a new surge in coronavirus cases, largely due to the Delta variant, which originally came from India.

Experts say the latest UK data will be given a lot of attention as it could be an editorial for others. And there are fears that where the UK is now performing, others – like the US – may follow suit.

“All eyes (are) on the UK Covid trends,” said Kallum Pickering, Senior Economist and Director of Berenberg Bank, in a statement on Tuesday.

“Great Britain, with its high vaccination rate but an increasing number of infections recorded daily, has developed into a test case for whether a mass vaccination against SARS-CoV-2 can bring” [an] End of the repeated cycles of lockdowns and other harsh social distancing protocols that have had a devastating impact on the global economy since the pandemic began in early 2019, “he said.

Pickering noted that medical data suggests that the UK’s high vaccination rate has severely weakened the link between registered Covid infections and complications from the disease, which supports the bank’s claim that “Britain can weather the new wave of infections without having to tighten the restrictions and “with only limited economic damage.”

Pickering said the data indicated that this wave of infections was different from the previous ones, with the number of registered infections increasing more slowly than the previous wave, and that despite the increase in cases, there has been no clear increase in deaths.

Second, he found that new admissions to the hospital had risen less than the registered infections – and much less than during the winter wave.

Reopening on track?

Deutsche Bank research strategist Jim Reid noted on Wednesday that while there is “persistent concern” about the spread of the Delta variant, “the only good news is that the age distribution of cases in the latest wave has moved significantly lower compared to the previous “. Waves.”

Younger age groups are affected by the virus much less often than older people. But the longer the boys remain unvaccinated or partially vaccinated, the virus is allowed to spread and possibly more variants can emerge.

So far, the vaccines have been shown to be resistant to new variants and remain largely effective in preventing serious Covid-19 for fully vaccinated people. An analysis published by Public Health England last Monday found that two doses of the Pfizer BioNTech or AstraZeneca Covid-19 vaccines were highly effective against hospitalizations from the Delta variant.

In order to fully vaccinate more people, the UK government has postponed the lifting of the remaining Covid restrictions in England until July 19. She has insisted that the lifting of restrictions on that date is still on track despite the proliferation of the Delta variant.

“The risk that the reopening could be reversed remains low,” said Pickering von Berenberg.

“The UK is far from where medical capacity could be stretched to the point where new restrictions would be required,” he noted, adding that the continued rapid introduction of vaccines in the coming weeks could even lead to that the daily infections run on a plateau before it falls afterwards.

“While the pandemic is far from over and potential new variants that render the current generation of vaccines ineffective are a serious risk, recent virus and vaccine developments support our positive economic outlook for the UK and other advanced economies,” he said.

Winter wave?

What will come later this year when the flu season starts is more uncertain. England’s chief medical officer warned last week that the coming winter will continue to be difficult for the country’s health system despite the country’s successful coronavirus vaccination program.

In a speech to the NHS Confederation last Thursday, England Chief Medical Officer Chris Whitty said the current wave of Covid infections due to the Delta variant is likely to be followed by a further surge in winter.

Covid-19 “didn’t bring us its final surprise and there will be a few more [variants] over the next period, “he said, according to Sky News. He added that it would likely be five years before there are vaccines that could highly” hold the line “against a range of coronavirus variants.

And until then, new vaccination programs and booster vaccinations are necessary. Some countries, like the US and UK, have already signaled that they could introduce Covid-19 booster vaccinations within a year, but pressure is mounting on governments to mobilize refresher programs – not an easy task given the ongoing uncertainties surrounding the pandemic , Vaccines and variants.

Categories
Health

Is the Compelled Contraception Alleged by Britney Spears Authorized?

Among the astounding claims pop star Britney Spears made this week before a probate judge in Los Angeles as she attempted to end her lengthy conservatoire stint, was one that profoundly shook experts on guardianship and reproductive rights. She said a team led by her father, who is her conservator, prevented her from having her IUD removed because the team didn’t want her to have more children.

“Forcing someone to use birth control against their will is a violation of basic human rights and physical autonomy, just as it would be to force someone to become or remain pregnant against their will,” said Ruth Dawson, Principal Policy Associate at Guttmacher Institute, a research group that supports reproductive rights.

Court-approved forced contraception is rare in conservatories. But the specter it conjures up – forced sterilization – has a grim, long history in the United States, especially against poor women, women of color, and inmates. In the early 20th century, the state-sanctioned practice was upheld by the United States Supreme Court.

Although the court moved away from this position in the 1940s and the growing consent canon gave rise to consensus that forced sterilization was inhuman, the practice continued to be tacitly tolerated.

Finally, in the late 1970s, most states repealed sterilization authorization laws, although allegations of forced hysterectomies and tubal ligatures in women in immigrant detention remain. As recently as 2014, California formally banned the sterilization of female inmates without consent.

The sparse law on the question at the Conservatory suggests what an outlier the Spears case might be. In 1985, the California Supreme Court denied a petition from the legal guardians of a 29-year-old woman with Down syndrome who wanted her to have tubal ligation.

Usually, a restorer has temporary control over the finances and even medical care of an incapacitated person. Experts emphasized that Ms. Spears’ claim is unconfirmed. But if it’s correct, they said, the most likely rationale, even if suspicious, could be that Jamie Spears, her father, is trying to protect her finances from the father of a baby, possibly her boyfriend who is allegedly at odds with Mr. Spears is.

When a guardian is concerned that a community is making financially ill-advised decisions, “the cure is not to say they cannot reproduce,” said Sylvia Law, a health scientist at New York University School of Law. “It’s ineffable.”

According to fiduciary and inheritance experts, the few cases where a guardian, usually a parent, ordered a court to order contraception concerned severely disabled children.

“Such a child would not understand that a penis and vagina could make a baby,” said Bridget J. Crawford, an expert on guardianship law at Pace University Law School. “And that’s certainly not the case with Britney Spears.”

Eugenics was a major reason for female sterilization. In the Buck v. Bell in 1927, the Supreme Court upheld the right to sterilize a “moronic” woman who had been admitted to a state mental health facility, with Judge Oliver Wendell Holmes notoriously writing: “Three generations of morons are enough. ”

Although the opinion was never formally overturned, Judge William O. Douglas said in a unanimous court in the Skinner v. Oklahoma of 1942, in which the forced sterilization of certain convicted criminals was challenged that the right to procreation was fundamental. “Every experiment that the state carries out is irreparable to it,” he wrote. “He is forever deprived of a fundamental freedom.”

Although Ms. Spears was not sterilized, Ms. Crawford said if she was prevented from having her IUD removed it would be a proxy for sterilization, especially since she testified that she wanted to bear more children.

Melissa Murray, who teaches reproductive rights and constitutional law in NYU law school, pointed to another worrying element in the allegations made by Ms. Spears, who at 39, has been under her father’s tutelage for 13 years. Ms. Murray said Ms. Spears, an adult, appeared to have a legally constructed childhood.

“It’s unusual for her father to make the decisions we would expect parents to make in a teenager,” she added.

Categories
Health

‘You understand it will occur’

President Joe Biden said Thursday that Covid deaths in the United States will continue to increase due to the spread of the “dangerous” Delta variant, calling it a “serious concern”.

“More than six hundred thousand Americans have died, and with this variation of the Delta, you know there will be others, too. You know it will happen. We need to vaccinate young people,” Biden said at a community center in Raleigh, North Carolina .

The variant, said Biden, is more easily transferable and potentially fatal and “especially dangerous for young people”.

The president warned that Americans who have not yet been vaccinated are particularly at risk.

“The data couldn’t be clearer: if you are vaccinated, you are safe,” said Biden. “You are still at risk of becoming seriously ill or dying if you actually aren’t vaccinated, that’s just a fact.”

According to data from the Centers for Disease Control and Prevention, the delta variant now accounts for at least 20% of all new Covid cases in the USA. The variant has a doubling rate of about two weeks, which puts it on the path to becoming the dominant strain in the U.S. in just a few weeks, said Chief White House medical advisor Dr. Anthony Fauci, on Wednesday.

The authority has described the more easily transferable variant as “questionable variant”.

Experts say the Delta variant could also cause more severe illness in those infected, but more data is needed to be certain.

Categories
Health

New Remedy for Aggressive Prostate Most cancers Improves Survival

An experimental therapy has prolonged life in men with aggressive prostate cancer that has resisted other treatments, offering new hope to patients with advanced illness and opening the door to a promising new form of cancer therapy.

Among men who received the new therapy, there was a nearly 40 percent reduction in deaths over the course of the clinical trial, compared with similar patients who received only standard treatment, researchers reported on Wednesday.

Prostate cancer is the second-leading cause of cancer death among American men, after lung cancer; an estimated 34,130 men will die of prostate cancer this year. One in eight men will be diagnosed with the disease at some point in their lives. The risk increases with age, and the cancer is more common in Black men.

The new treatment relies on a radioactive molecule to target a protein found on the surface of prostate cancer cells. The study, which followed 831 patients with advanced disease in 10 countries for a median period of 20 months, was published in The New England Journal of Medicine.

“This is something new — you’re driving radiation right to the cancer itself,” said Karen Knudsen, president and chief executive of the American Cancer Society. “It’s a much more sophisticated strategy for targeting the tumor.”

“You’re not just destroying the cancer cells — you’re smart-bombing the place that the tumor has found for itself to live.”

There is no definitive cure for metastatic prostate cancer, and there is an urgent need for new therapies, Dr. Knudsen said. Most life-extending treatments rely on suppressing or blocking androgens, the male hormones that fuel prostate cancer.

“This opens the door to precision radiotherapy targeted at other molecules that are on the surface of other cancer cells,” said Dr. Philip Kantoff, chairman of medicine at Memorial Sloan Kettering Cancer Center in New York.

The investigational treatment, called lutetium-177-PSMA-617, combines a compound that targets a protein on the surface of prostate cancer cells, called prostate-specific membrane antigen, or P.S.M.A., with a radioactive particle that attacks the cells.

The P.S.M.A. protein, which can be detected by imaging scans, is almost exclusively on prostate cancer cells, and so the treatment causes less damage to surrounding tissue, said Dr. Oliver Sartor, the trial’s co-principal investigator and medical director of Tulane Cancer Center in New Orleans.

Though the protein is not ubiquitous in prostate tumors, it is found in more than 80 percent of cases. Among patients screened for the trial, 87 percent were P.S.M.A.-positive. Only those men who were positive for the marker were included in the trial.

The study enrolled men with a form of metastatic prostate cancer called castration-resistant prostate cancer. All the patients had disease that progressed despite treatments with chemotherapy and hormonal therapy to suppress and block androgens.

Participants were randomly assigned to receive the experimental treatment, given every six weeks in up to six doses along with standard treatment, or to continue standard care alone, but without chemotherapy or other isotopes.

After a median follow-up period of 20.9 months, patients given the experimental treatment survived for a median of 15.3 months, compared with 11.3 months for those who received only standard care, a reduction of 38 percent.

Their tumors were more likely to shrink, their prostate-specific antigen levels were more likely to fall, and the risk of their cancer progressing was reduced by 60 percent.

Side effects — most commonly fatigue, dry mouth and nausea — were more prevalent among those receiving the compound than among those who did not, but did not appear to significantly affect quality of life, the researchers said.

The study had some limitations. It was a randomized trial, but because of the difficulties of running a double-blinded trial with a radioactive treatment, the trial was open-label: Both patients and physicians knew whether or not they were getting the treatment. That caused some problems early on, as patients who were disappointed by their assignment withdrew from the trial.

The investigational drug worked where other approaches had failed, Dr. Sartor emphasized. “These patients had received essentially all the available therapies,” he said. “This is the first drug targeted to the tumor that actually results in overall survival benefit among incredibly, heavily pretreated patients.”

Dr. Sartor was a co-principal investigator of the trial, along with Dr. Bernd Krause, of Rostock University Medical Center in Germany. The trial was sponsored by Endocyte Inc. and Advanced Accelerator Applications, which are Novartis companies; Dr. Sartor is a paid consultant to the company. The data were analyzed by the sponsor and provided confidentially to the authors.

Officials with Novartis said the company will apply to the Food and Drug Administration for approval of the new treatment later this year.

Categories
Health

Ceremony Assist plummets; CEO Heyward Donigan cites Covid for cautious outlook

Rite Aid CEO Heyward Donigan told CNBC on Thursday she’s “cautiously optimistic” the U.S. would avoid another round of strict Covid restrictions despite the presence of the delta variant.

“We all hope that enough people get vaccinated that we don’t have the variant become so significant that our markets shut down again,” Donigan said on “Squawk Box.”

Even so, the chief executive said the drug store chain was being judicious with its financial projections due, in part, to how unpredictable the coronavirus pandemic’s impact on business has been.

Shares of Rite Aid sank roughly 14% on Thursday, sending the company’s stock market value under $1 billion, as Wall Street digested mixed first-quarter results and weaker earnings guidance.

Rite Aid’s forecast for adjusted EBITDA — earnings before interest, taxes, depreciation and amortization — came in at $440 million and $480 million in fiscal year 2022, below estimates of $524 million, according to FactSet.

“We’re being very cautious because we had a miss last quarter due to the complete meltdown, I’ll call it, of cough, cold, flu — both in the pharmacy and in the front end because there just was no cough, cold, flu,” Donigan said, alluding to the recent surprisingly calm flu season in the U.S. and its impact on Rite Aid.

“We just didn’t realize how far down, how evaporated that business would actually be. So as we look forward, we think we need to be very cautious and prudent in our guidance,” said Donigan, who has been CEO of Pennsylvania-based Rite Aid since August 2019.

“We are expecting some improvement. We’re not expecting full improvement,” Donigan added.

She also acknowledged, “It’s very hard, it remains very hard to predict, a full-year result in a retail pharmacy in the middle of a pandemic because we are … still in the throes of this to some degree.”

The company projected full-year revenue of between $25.1 billion and $25.5 billion, which exceeded Wall Street’s expectations of $24.66 billion, according to FactSet.

Rite Aid’s outlook is not factoring in potential Covid vaccine boosters or vaccinations for children under the age of 12, Donigan noted. Trials examining the vaccine in kids under age 12 are currently ongoing.

The Food and Drug Administration cleared Pfizer’s Covid vaccine for use in kids ages 12 to 15 a little more than a month ago. Moderna, which also makes a two-dose vaccine, has asked the FDA to expand its emergency use authorization to cover adolescents from 12 to 17.

Categories
Health

A Coronavirus Epidemic Hit 20,000 Years In the past, New Research Finds

Researchers have found evidence that a coronavirus epidemic swept East Asia about 20,000 years ago and was devastating enough to leave an evolutionary imprint on the DNA of people living today.

The new study suggests that the region was plagued by an ancient coronavirus for many years, researchers say. The finding could have devastating effects on the Covid-19 pandemic if it is not brought under control soon with vaccinations.

“It should worry us,” said David Enard, an evolutionary biologist at the University of Arizona who led the study, which was published Thursday in the journal Current Biology. “What is happening now could last for generations.”

So far, researchers have not been able to look very far back into the history of this family of pathogens. Over the past 20 years, three coronaviruses have adapted to infect people and cause serious respiratory illnesses: Covid-19, SARS, and MERS. Studies on each of these coronaviruses suggest that they jumped into our species from bats or other mammals.

Four other coronaviruses can also infect people, but usually only cause mild colds. Scientists didn’t directly observe how these coronaviruses became human pathogens, so they relied on indirect clues to gauge when the jumps happened. Coronaviruses acquire new mutations at roughly regular rates, and so by comparing their genetic variation it can be determined when they deviated from a common ancestor.

The youngest of these mild coronaviruses, called HCoV-HKU1, crossed species boundary in the 1950s. The oldest, called HCoV-NL63, can be up to 820 years old.

But before that, the coronavirus trail got cold – until Dr. Enard and his colleagues applied a new method to the search. Instead of looking at the coronavirus genes, the researchers looked at the effects on the DNA of their human hosts.

Viruses cause enormous changes in the human genome over generations. A mutation that protects against a viral infection can make the difference between life and death and is passed on to the offspring. For example, a life-saving mutation could allow humans to hack up the proteins of a virus.

But viruses can also develop. Your proteins can change shape to overcome a host’s defenses. And these changes could spur the host to develop even more counter-offensives, which leads to more mutations.

If a random new mutation creates resistance to a virus, it can quickly become more common from one generation to the next. And other versions of this gene are becoming rarer. So if, in large groups of people, one version of a gene dominates all the others, scientists know that it is most likely a sign of rapid evolution in the past.

In recent years, Dr. Enard and his colleagues searched the human genome for these genetic variation patterns to reconstruct the history of a number of viruses. When the pandemic broke out, he wondered if ancient coronaviruses had left their own mark.

He and his colleagues compared the DNA of thousands of people from 26 different populations around the world, looking at a combination of genes known to be critical for coronaviruses but not other types of pathogens. In East Asian populations, the scientists found that 42 of these genes had a dominant version. That was a strong signal that people in East Asia had adapted to an ancient coronavirus.

But whatever happened in East Asia seemed to be confined to that region. “When we compared them to populations around the world, we couldn’t find the signal,” said Yassine Souilmi, postdoctoral fellow at the University of Adelaide in Australia and co-author of the new study.

The scientists then tried to estimate how long East Asians had already adapted to a coronavirus. They took advantage of the fact that once a dominant version of a gene begins to be passed down through the generations, it can acquire harmless random mutations. The more time passes, the more of these mutations accumulate.

Dr. Enard and his colleagues found that all 42 genes had about the same number of mutations. That meant they had all evolved rapidly at about the same time. “This is a signal that we should definitely not expect by chance,” said Dr. Enard.

They estimated that all of these genes developed their antiviral mutations sometime between 20,000 and 25,000 years ago, most likely over the course of a few centuries. This is a surprising finding, since the East Asians did not live in dense communities at the time, but rather formed small groups of hunters and gatherers.

Aida Andres, an evolutionary geneticist at University College London who was not involved in the new study, said she found the work compelling. “I’m pretty sure there is something,” she said.

Still, she didn’t think it was possible to give an accurate estimate of how long ago the ancient epidemic was. “Timing is a complicated thing,” she said. “Whether that happened a few thousand years before or after – I personally think that we can’t be so sure about it.”

Scientists looking for drugs to fight the new coronavirus may want to study the 42 genes that evolved in response to the old epidemic, said Dr. Souilmi. “It actually points us out to molecular buttons to adjust the immune response to the virus,” he said.

Dr. Anders agreed, saying that the genes identified in the new study should receive special attention as drug targets. “You know they are important,” she said. “That’s the beauty of evolution.”

Categories
Health

Here is what you might want to know

June 2021, people are standing in front of a vaccination center in Sydney as residents have largely been banned from leaving the city in order to stop a growing outbreak of the highly contagious Delta-Covid-19 variant in other regions.

SAEED KHAN | AFP | Getty Images

The “Delta variant” dominated the headlines after it was discovered in India, where it sparked an extreme spike in Covid-19 cases before spreading around the world.

But now a mutation of this variant has emerged, known as “Delta plus”, which worries global experts.

India has named Delta Plus a “worrying variant” and there are fears that it could potentially be more transferable. In the UK, Public Health England noted in its last roundup that routine scanning of Covid cases in the country (where the Delta variant is now responsible for the bulk of new infections) found nearly 40 cases of the Delta variant that the Spike protein mutation K417N, ie Delta plus.

It found that by June 16 there were also cases of the Delta Plus variant in the United States (83 cases at the time the report was published last Friday), as well as in Canada, India, Japan, Nepal, Poland, Portugal, Russia, Switzerland and Turkey.

India third wave?

As usual with all viruses, the coronavirus has mutated repeatedly since its appearance in China in late 2019. As the pandemic progressed, a handful of variants have emerged that have altered the communicability, risk profile, and even symptoms of the virus.

Read more: The rapidly spreading Delta Covid variant could have different symptoms, experts say

Several of these variants, such as the “Alpha” variant (formerly known as “Kent” or “British” variant) and then the Delta variant, have become dominant varieties worldwide, hence the attention to Delta Plus.

The Indian Ministry of Health reportedly said on Wednesday that it had found around 40 cases of the Delta Plus variant with the K417N mutation. The ministry released a statement Tuesday saying that INSACOG, a consortium of 28 laboratories that are sequencing the virus in India during the pandemic, had told it that the Delta Plus variant had three properties of concern.

These are: increased transmissibility, stronger binding to receptors on lung cells, and the potential reduction in monoclonal antibody response (which could reduce the effectiveness of life-saving monoclonal antibody therapy in some hospitalized Covid patients).

The Indian Ministry of Health said it had alerted three states (Maharashtra, Kerala and Madhya Pradesh) after the Delta Plus variant was discovered in genome-sequenced samples from these areas.

The discovery of a variation on the Delta variant, largely blamed for India’s catastrophic second wave of cases, has raised fears that India is ill-prepared for a possible third wave. But some experts call for calm.

DR. Chandrakant Lahariya, A doctor, epidemiologist and vaccine and health systems expert based in New Delhi told CNBC on Thursday that while the government should remain vigilant on the progress of the variant, there is “no need to panic”.

“Epidemiologically, I have no reason to believe that ‘Delta plus’ is changing the current situation to accelerate or trigger the third wave,” he told CNBC via email.

“If we stick to the evidence currently available, Delta plus is not very different from the Delta variant. It’s the same Delta variant with an additional mutation. The only clinical difference we know of so far is that Delta plus some resistance to monoclonal antibody combination therapy. And that’s not much of a difference since the therapy itself is under investigation and few are suitable for this treatment. “

He advised the public to follow the Covid restrictions and get vaccinated as soon as possible. An analysis published last week by Public Health England showed that two doses of the Pfizer BioNTech or Oxford AstraZeneca Covid-19 vaccines are highly effective against hospitalizations from the Delta variant.

The WHO has stated that it is following recent reports of a “Delta Plus” variant. “An additional mutation … has been identified,” said Maria Van Kerkhove, WHO technical director for Covid-19, at a briefing last week.

“In some of the Delta variants, we saw one less mutation or one deletion instead of an additional one, so let’s look at everything.”